Meta-analysis shows comorbid association between migraine and epilepsyJanuary 20, 2024Headache & Migraine
Erenumab demonstrates more favorable efficacy than rimegepant for migraine preventionJanuary 20, 2024Headache & Migraine
Genetic factors influence response to anti-CGRP antibodies in migraineJanuary 20, 2024Headache & Migraine
Agomelatine offers an effective preventive treatment for episodic migraine without auraJanuary 20, 2024Headache & Migraine
Considering high-dose EPA/DHA as a primary option for migraine preventionJanuary 20, 2024Headache & Migraine
Elevated odds of motor vehicle crashes in older adults after newly diagnosed migraineJanuary 20, 2024Headache & Migraine
Commentary: Examining CGRP Antagonists for Migraine Relief, January 2024December 23, 2023Headache & Migraine
Fremanezumab benefits migraine patients with inadequate response to prior preventive medicationsDecember 19, 2023Headache & Migraine
Galcanezumab and rimegepant offer effective options for prevention of episodic migraineDecember 19, 2023Headache & Migraine
Galcanezumab and rimegepant offer effective options for prevention of episodic migraineDecember 19, 2023Headache & Migraine
Comparative efficacy of anti-CGRP mAb in chronic and high-frequency episodic migraineDecember 19, 2023Headache & Migraine
